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Introduction
FAK-family interacting protein of 200 kD (FIP200; also known 
as RB1CC1, or RB1-inducible coiled-coil 1) encodes a 200-kD 
protein (1591 aa) characterized by a large coiled-coil region 
(CC; residues 860–1391) containing a leucine zipper motif 
 (residues 1371–1391; Ueda et al., 2000; Chano et al., 2002b). 
FIP200 was originally identifi  ed by us as a Pyk2 interacting pro-
tein through a yeast two-hybrid screen (Ueda et al., 2000). It was 
shown to interact with Pyk2 kinase domain and inhibit its kinase 
activity in in vitro kinase assays (Ueda et al., 2000). FIP200 was 
subsequently also shown to interact with FAK and function 
to inhibit FAK activity and autophosphorylation as well as 
FAK-promoted cellular functions, including cell spreading, cell 
migration, and cell cycle progression (Abbi et al., 2002). Shortly 
after these studies, FIP200 was also independently identifi  ed by 
Chano et al. (2002a) as a potential regulator of the RB1 gene.
Recent studies suggest that the tuberous sclerosis complex 
(TSC)–mammalian target of rapamycin (mTOR) signaling net-
work plays an essential role in the regulation of cell growth 
(Kwiatkowski, 2003; Fingar and Blenis, 2004; Hay and Sonenberg, 
2004). TSC1 and -2 are both tumor suppressor genes responsible 
for tuberous sclerosis, which is characterized by the formation of 
hamartomas in a wide range of tissues. TSC1 and -2 can form a 
physical and functional complex in vivo (Kwiatkowski, 2003) 
and function as potent negative regulators of cell growth mainly 
by their inhibition of mTOR and its targets ribosomal S6 kinase 
(S6K) and eukaryotic initiation factor 4E binding protein 1 
(4EBP1), which play essential roles in the regulation of protein 
synthesis and cell size. Recent studies suggested that TSC2 
functions as the GTPase-activating protein of the small G pro-
tein Rheb, an upstream activator of mTOR, and that the TSC1–
TSC2 complex antagonizes the mTOR signaling pathway via 
stimulation of GTP hydrolysis of Rheb (Manning and Cantley, 
2003; Inoki et al., 2005). Interestingly, we have recently found a 
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ocal adhesion kinase family interacting protein of 
200 kD (FIP200) has been shown to regulate di-
verse cellular functions such as cell size, prolifera-
tion, and migration in vitro. However, the function of 
FIP200 in vivo has not been investigated. We show that 
targeted deletion of FIP200 in the mouse led to embry-
onic death at mid/late gestation associated with heart 
failure and liver degeneration. We found that FIP200 
knockout (KO) embryos show reduced S6 kinase acti-
vation and cell size as a result of increased tuberous 
sclerosis complex function. Furthermore, FIP200 KO 
embryos exhibited signiﬁ  cant apoptosis in heart and liver. 
Consistent with this, FIP200 KO mouse embryo ﬁ  bro-
blasts and liver cells showed increased apoptosis and 
reduced c-Jun N-terminal kinase phosphorylation in re-
sponse to tumor necrosis factor (TNF) α stimulation, 
which might be mediated by FIP200 interaction with 
apoptosis signal–regulating kinase 1 (ASK1) and TNF 
receptor–associated factor 2 (TRAF2), regulation of 
TRAF2–ASK1 interaction, and ASK1 phosphorylation. 
Together, our results reveal that FIP200 functions as a 
regulatory node to couple two important signaling 
pathways to regulate cell growth and survival during 
mouse embryogenesis.
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potentially novel function for FIP200 in the regulation of cell 
growth through its interaction with TSC1 and inhibition of 
TSC1–TSC2 complex function (Gan et al., 2005).
During embryonic development, cell survival/death is 
tightly regulated by both intrinsic and extrinsic factors. The in-
trinsic death pathway is activated by the release of cytochrome c 
from mitochondria in response to various stress and develop-
mental death cues, whereas the extrinsic death pathway is mainly 
activated by the binding of death receptors of the TNF receptor 
(TNFR) superfamily to their ligands. One of the ligands of death 
receptors is TNFα. The binding of TNFα to its receptor TNFR1 
triggers several intracellular events that regulate both cell sur-
vival and cell death. TNFα-induced cell death is mainly medi-
ated by the activation of caspase-8, whereas cell survival effect 
of TNFα is mainly mediated by the NF-κB pathway (Chen and 
Goeddel, 2002; Ghosh and Karin, 2002). TNFα stimulation can 
also activate JNK through TNFR1–TNFR-associated factor 2 
(TRAF2)–apoptosis signal–regulating kinase 1 (ASK1)–MAPK 
kinase (MKK) 4/7–JNK signaling cascade (Nishitoh et al., 1998; 
Davis, 2000). However, the exact role of JNK in TNFα-
  stimulated cell death signaling is complicated, as JNK has been 
found to play both antiapoptotic and proapoptotic roles in TNFα 
signaling in different cellular contexts. A recent study showed 
that JNK1 and -2 double-knockout (KO) mouse embryo fi  bro-
blasts (MEFs) exhibited increased TNFα-stimulated apoptosis, 
  suggesting, at least in MEFs, that JNK could mediate a survival 
response in TNFα signaling (Lamb et al., 2003). Mice KO 
  studies highlight the important role of TNFα signaling in the 
regulation of cell survival/death during embryonic development. 
Deletion of some of the genes involved in TNFα signaling, such 
as Rel A (a subunit of NF-κB), IκB kinase β, and IκB kinase γ, 
leads to mid/late gestational lethality associated with increased 
apoptosis in liver, indicating the role of TNFα signaling in the 
regulation of cell survival and death in the liver development 
during embryogenesis (Beg et al., 1995; Li et al., 1999; Rudolph 
et al., 2000).
FIP200 is widely expressed in various human tissues 
(Bamba et al., 2004) and is an evolutionarily conserved protein 
present in human, mouse, rat, Xenopus laevis, Drosophila 
 melanogaster, and Caenorhabditis elegans. The high degree of 
conservation during evolution suggests that FIP200 plays impor-
tant functions in vivo. Despite these recent studies suggesting a 
role of FIP200 in the regulation of a variety of cellular functions 
in vitro, however, the function of FIP200 in vivo remains totally 
unknown. In the present study, we generated FIP200 KO mouse 
to study the physiological role of FIP200 in vivo. The analyses 
Figure 1.  Generation of FIP200 KO mice. (A) Schematic rep-
resentation of the FIP200 targeting vector, mouse FIP200 ge-
nomic structure, and the loxP modiﬁ  ed FIP200 loci. Large solid 
triangles represent loxP sites. The relevant restriction sites 
(B, BglII; N, NcoI), position of probe (thick line) for Southern 
blotting, and primers (P1, P2, and P3) for PCR genotyping are 
indicated. Crosses of the mice with targeted allele with EIIa 
Cre mice result in three possible outcomes at the FIP200 loci 
(Neo, ﬂ  ox, and ∆ allele). (B) Southern blotting analysis of the 
DNA extracted from ES cells after digestion with correspond-
ing restriction enzymes as indicated. (C) Genomic DNA was 
extracted from mouse tail and analyzed by PCR (left) and 
Southern blotting (right), as indicated, to distinguish different 
types of alleles resulting from Cre-mediated recombination. 
(D) Western blotting analysis of protein extracts from whole 
embryos with various genotypes by anti-FIP200 or anti-vinculin, 
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of FIP200 KO embryos and isolated cells reveal the important 
function of FIP200 in cell size control and cell survival during 
embryogenesis and highlight a previously unappreciated role of 
FIP200 in TNFα-JNK signaling.
Results
Ablation of FIP200 in mouse leads to 
embryonic lethality at mid/late gestation
To study the potential function of FIP200 in vivo, we generated 
a mouse strain that contains three loxP sequences that fl  ank the 
exons 4 and 5 of mouse FIP200 gene and a neo cassette (FIP-
200
fl  oxNeo/+) via a standard homologous recombination technique 
(Fig. 1, A and B). The FIP200
fl  oxNeo/+ mice were crossed with 
EIIa-Cre mice (Lakso et al., 1996), which led to the generation 
of three types of offspring: fl  ox allele with neo cassette deleted 
(FIP200
fl  ox/+), neo allele with exons 4 and 5 deleted (FIP-
200
Neo/+), and total deletion allele with both exons 4 and 5 and 
neo cassette deleted (FIP200
∆/+; Fig. 1 A). Cre-mediated dele-
tion of exons 4 and 5 leads to a frame-shift mutation because of 
direct splicing from exon 3 (containing ATG codon) to exon 6, 
producing a small truncated and nonfunctional peptide. The 
FIP200
∆/+ and FIP200
fl  ox/+ mice were identifi  ed by PCR analy-
sis of tail DNA (Fig. 1 C, left), and the PCR results were con-
fi  rmed by Southern blotting (Fig. 1 C, right).
FIP200
∆/+ mice are normal and fertile and were inter-
crossed to generate FIP200 KO mice. Genotyping of >300 
weaning-age pups identifi  ed no homozygous mice, whereas a 
Mendelian ratio of nearly 1:2 was found for wild-type (WT) and 
heterozygous pups, suggesting that deletion of the FIP200 gene 
results in embryonic lethality. Mating between heterozygous 
FIP200
fl  ox/+ mice yielded homozygous fl   oxed FIP200 mice 
(FIP200
fl  ox/fl  ox) at the expected Mendelian ratio, and FIP200
fl  ox/fl  ox 
mice were viable and fertile and did not show any gross or histo-
logical abnormalities (unpublished data), further confi  rming that 
the embryonic lethality for FIP200
∆/∆ mice is caused by FIP200 
gene ablation.
Extensive timed matings were then performed to determine 
when FIP200 KO embryos die and to characterize phenotypic 
  defects in the KO embryos. Embryos were analyzed from embry-
onic day (E) 9.5 to birth (Table I). The normal Mendelian ratio 
of 1:2:1 of WT, heterozygous, and homozygous embryos was 
  observed until E13.5. Approximately 25 and 60% of homozygous 
embryos were found dead at E14.5 and E15.5, respectively, and 
the total number of homozygous embryos (including both alive 
and dead embryos) at each day were very close to the number of 
WT embryos. No live FIP200 KO embryos were identifi  ed at 
E16.5 and thereafter. The small size and autolysis of the dead KO 
embryos recovered after E16.5 are compatible with embryonic 
  lethality between E13.5 and E16.5. Analysis of extracts from 
whole embryos verifi  ed the absence of FIP200 in homozygous KO 
embryos and reduced expression of FIP200 in the heterozygotes 
(Fig. 1 D). Together, these results show that homozygous deletion 
of FIP200 leads to embryonic lethality at mid/late gestation.
Defective heart and liver development 
in FIP200 KO embryos
Gross examination of the embryos showed normal morphology 
for FIP200 KO embryos until E12.5 (Fig. 2 A). At E13.5,  20% 
of the FIP200 KO embryos were pale, and at E14.5 and E15.5 
the majority of them were pale compared with WT littermates. 
Histological studies of the FIP200 KO embryos showed severe 
cardiac abnormalities characterized by ventricular dilation, sparsely 
cellular myocardium (Fig. 2 B), and generalized edema (Fig. 2 C) 
in a majority of the FIP200 KO embryos analyzed at E14.5 and 
E15.5. The heart ventricular wall in KO embryos has lost the 
normal trabecular and external compact myocytes, and the wall 
was signifi  cantly thinner and contained fewer cells when com-
pared with the WT littermates (Fig. 2 B). In the most   severely 
  affected mutants, the myocardium appears to be composed almost 
entirely of the trabecular layer with no appreciable compact layer 
underneath the epicardium. In a majority of the FIP200 KO 
  embryos analyzed at E14.5 and E15.5, we also observed liver 
  lesions characterized by loosely arranged hepatocytes mixed with 
numerous red blood cells (Fig. 2 D). Hepatocytes were separated 
from each other with disrupted   architecture because of dissecting 
hemorrhage in between the hepatic cords (Fig. 2 D). Histological 
examination of FIP200 KO embryos at E14.5 and E15.5 showed 
apparently normal morphogenesis of the other major   organs as 
well as extraembryonal tissues, including the placenta (unpub-
lished data).   Together, these results suggest that the signifi  cant 
defects in the formation and development of the myocardium 
and liver are the most likely cause of the embryonic lethality 
  observed in FIP200 KO embryos.
Table I. Genotypes of progeny from FIP200
+/𝖫 heterozygous intercrosses
Embryonic day +/++ /𝖫𝖫 /𝖫 (alive) 𝖫/𝖫 (dead) Total Litter no.
E9.5 6 11 8 0 25 3
E10.5 8 18 9 0 35 4
E11.5 7 17 7 0 31 4
E12.5 7 18 8 0 33 4
E13.5 15 29 16 0 60 8
E14.5 44 86 31 10 171 22
E15.5 22 32 9 12 79 10
E16.5 8 13 0 5 26 3
E17.5 7 9 0 5 21 3
E18.5 4 7 0 4 15 2
Postnatal 101 205 0 0 306 51JCB • VOLUME 175 • NUMBER 1 • 2006  124 
FIP200 deletion leads to increased TSC 
function and corresponding reduction 
of cell size in vivo
Our previous studies showed FIP200 interaction with TSC1 and 
inhibition of TSC function in cell size control in vitro (Gan 
et al., 2005). Interestingly, TSC1 KO embryos also exhibited 
defects in both heart and liver, with thickened ventricular walls 
(Kobayashi et al., 2001; Kwiatkowski et al., 2002). Therefore, 
deletion of a putative inhibitor of TSC, FIP200, could lead to 
the thin ventricular walls in the FIP200 KO embryos. To test 
this possibility and investigate the cellular and molecular mech-
anisms of FIP200 function in embryogenesis, we examined the 
effect of FIP200 deletion on TSC functions and cell size regula-
tion in vivo. Embryo sections were analyzed for the activity of 
S6K, a major target of the TSC–mTOR signaling pathway, by 
immunohistochemical staining with antibodies against phos-
phorylated S6. We found that FIP200 KO embryos showed gen-
erally weaker staining for phospho-S6 compared with WT 
littermate embryos (unpublished data). In particular, signifi  -
cantly decreased staining for phospho-S6 was found in heart 
and liver (Fig. 3 A). Western blotting analysis of protein extracts 
from heart and liver confi  rmed reduced phosphorylation of S6, 
S6K, and 4EBP1 in FIP200 KO embryos compared with the 
WT littermates (Fig. 3 B). Furthermore, we did not observe any 
change in the expression levels of TSC1 or -2 or the phosphory-
lation of Akt or TSC2 in the heart and liver from FIP200 KO 
embryos compared with that from the WT embryos (Fig. 3 B).
Our previous study showed that FIP200 KO MEFs exhib-
ited decreased S6K activation (Gan et al., 2005). Consistent with 
this, we also found decreased cell size in FIP200 KO MEFs com-
pared with WT MEFs (Fig. 3 C). We then examined the cell size 
in FIP200 KO embryos by staining with wheat germ agglutinin 
(WGA)–tetramethyl rhodamine isothiocyanate (TRITC), which 
outlines the cell membranes in the tissue sections (Bueno et al., 
2000). Fig. 3 D shows a decreased cell size in both heart and liver 
in FIP200 KO embryos compared with WT littermates. Quantita-
tive analysis of multiple samples suggested an  33 and 25% re-
duction of mean cell size in heart and liver, respectively (Fig. 3 E). 
The decreased S6 phosphorylation and cell size were found in 
FIP200 KO embryos at E14.5 as well as E12.5 and E13.5 when 
there was no apparent histological defect in FIP200 KO embryos. 
Therefore, the decreased S6 phosphorylation and cell size were 
unlikely to be an indirect consequence of other defects (such as 
apoptosis; see the following paragraph) in FIP200 KO embryos. 
Together, these results suggested that, consistent with our previ-
ous fi  ndings in vitro (Gan et al., 2005), FIP200 functions as an 
inhibitor for TSC, and deletion of FIP200 could lead to increased 
TSC activity and corresponding decreases in S6K activation and 
cell size in the embryos.
Role of FIP200 in the regulation 
of apoptosis and cell survival 
in embryogenesis
Although the decreased cell size could contribute to the thin ven-
tricular wall defect in the FIP200 KO embryos, we also observed 
a reduced number of cells in the mutant embryo heart that could 
not be explained by reduction in cell size. This could be caused 
by either a decreased cell proliferation or an increased apoptosis 
or both in the FIP200 KO embryos. Analysis of heart and liver 
sections from FIP200 KO embryos at E13.5–15.5 by immunohis-
tochemical staining of proliferating cell nuclear antigen showed 
no apparent difference from WT littermate samples (unpublished 
data). In contrast, signifi  cantly increased apoptosis was found in 
the mutant heart as measured by immunohistochemical staining 
Figure 2.  Defective heart and liver develop-
ment in FIP200 KO embryos. (A) Gross exami-
nation of whole mount FIP200 WT (+/+) and 
KO (∆/∆) embryos at E12.5, E14.5, and 
E15.5. Note the paleness of FIP200 KO em-
bryos compared with WT littermates at E14.5 
and E15.5. (B) Histological sections from the 
heart of FIP200 WT (+/+) and KO (∆/∆) em-
bryos at E14.5. The heart in the KO embryo 
shows marked left ventricular dilation and a 
sparsely cellular thin wall that is composed of 
wisps of thin trabecular myocardium and is de-
void of the compact subepicardial myocar-
dium. fw, left ventricular free wall; tm, trabecular 
myocardium. (C) Histological sections of skin 
from the dorsum of FIP200 WT (+/+) and KO 
(∆/∆) embryos at E14.5. The marked expan-
sion of the subcutis, the mild expansion of the 
dermis, and the thin, undulating epidermis are 
indicative of acute edema. ed, epidermis; d, 
dermis; sc, subcutis; bf, brown fat. (D) Histo-
logical sections of liver FIP200 WT (+/+) and 
KO (∆/∆) embryos at E14.5. Liver from KO 
embryo showed disrupted architecture with 
loss of hepatocytes and multifocal variable 
sized hemorrhages. Also note that many hepa-
tocytes have condensed nuclei (karyopyknosis; 
red arrow) or fragmented nuclei (karyorrhexis; 
yellow arrow) or lost their nuclei (karyolysis; 
black arrow) in the KO embryo (bottom right).FIP200 IN EMBRYONIC DEVELOPMENT AND SIGNALING • GAN ET AL. 125
for cleaved caspase-3 at E14.5, whereas no signifi  cant  sig-
nals  were detected at E12.5 or the WT littermates at E12.5 
or E14.5 (Fig. 4 A).
Consistent with the increased apoptosis in the mutant 
heart, signs of cell death were also observed in the liver of 
FIP200 KO embryos at both E14.5 and E15.5 (Fig. 2 D). Immuno-
histochemical staining for cleaved caspase-3 of liver sections 
confi  rmed signifi  cantly increased apoptosis in FIP200 KO em-
bryos at E14.5 (Fig. 4 B) and E15.5 (not depicted) compared 
with WT littermates. The majority of the apoptotic cells were 
identifi  ed as hepatocytes based on their larger size with large eo-
sinophilic cytoplasm and large, vesicular, single, round nucleus 
possessing a single, prominent, central nucleolus, compared 
with hematopoietic cells present in the liver. Interestingly, the 
increased apoptosis in the mutant embryos appeared to be re-
stricted to the liver and heart, as other organs of the FIP200 KO 
embryos did not show an obvious increase in cleaved caspase-3 
staining (unpublished data). As observed in the heart, no in-
creased apoptosis was found for the liver of mutant embryos at 
E12.5. Together, these results suggest that increased apoptosis, 
rather than decreased proliferation, is responsible for the de-
creased cell number of the thin ventricular walls as well as liver 
lesions in the FIP200 KO embryos.
FIP200 deletion leads to increased 
susceptibility to TNF𝗂-induced apoptosis
To understand the mechanism of regulation of apoptosis by 
FIP200, we isolated primary MEFs from FIP200 KO and WT 
littermate embryos. Under normal culture conditions, FIP200 
KO MEFs did not show increased apoptosis compared with the 
WT MEFs. Furthermore, FIP200 KO and WT MEFs showed a 
similar extent of apoptosis upon several apoptotic stimuli, such 
as glucose depletion and sorbitol and anisomycin treatment. In 
contrast, FIP200 KO MEFs showed an elevated sensitivity to 
TNFα-induced apoptosis compared with WT MEFs (Fig. 5 A). 
Consistent with previous studies  (Hoefl  ich et al., 2000; Rudolph 
et al., 2000; Lamb et al., 2003), TNFα treatment did not cause 
signifi  cant apoptosis in WT MEFs (Fig. 5 A). Interestingly, it 
induced signifi  cant apoptosis in the FIP200 KO MEFs compared 
with the untreated cells, suggesting an increased susceptibility 
Figure 3.  Reduced S6K activity and cell size 
in FIP200 KO embryos. (A) Immunohistochemi-
cal staining of heart and liver sections from 
FIP200 WT (+/+) and KO (∆/∆) embryos at 
E12.5 with Ser240/244 phospho-S6 anti-
body. Note that phospho-S6 staining signal is 
reduced in these organs in the FIP200 KO em-
bryos. (B) Heart and liver protein extracts pre-
pared from FIP200 WT (+/+) and KO (∆/∆) 
embryos were analyzed by Western blotting 
using various antibodies, as indicated. Alter-
natively, they were immunoprecipitated by 
anti-S6K and analyzed by Western blotting us-
ing antibody against Thr389 phospho-S6K 
and S6K. (C, top) Histograms of mean FSC-H 
comparing primary FIP200 WT and KO MEFs. 
(bottom) Relative mean FSC-H + SEM for three 
independent experiments (results are normal-
ized to FIP200 WT MEFs). *, P < 0.05. 
(D and E) Heart and liver sections from FIP200 
WT (+/+) and KO (∆/∆) embryos at E12.5 
were stained with WGA-TRITC. (D) Represen-
tative ﬁ  elds for each section. (E) Mean + SEM 
of calculated area of cross sections of cells 
from three independent experiments in multiple 
ﬁ  elds. **, P < 0.001.JCB • VOLUME 175 • NUMBER 1 • 2006  126 
to TNFα-induced apoptosis. In contrast, deletion of FIP200 did 
not sensitize cells to FAS-L– and TRAIL-induced apoptosis in 
MEFs (Fig. 5 A), suggesting that FIP200 plays a specifi  c role in 
TNFα-induced apoptosis. Furthermore, it appears that TNFα-
induced necrosis was not increased in FIP200 KO MEFs (Fig. 5 B). 
To verify that the increased cell death was caused by apoptosis, 
lysates from FIP200 KO and WT MEFs that had been treated 
with TNFα or untreated cells were analyzed by Western blotting 
for cleaved caspase-3, a marker of apoptotic cell death. Fig. 5 C 
shows that TNFα treatment induced an increased amount of 
cleaved caspase-3 in FIP200 KO but not WT MEFs. Further-
more, reexpression of FIP200 in FIP200 KO MEFs signifi  cantly 
abolished increased caspase-3 cleavage and apoptosis by TNFα 
treatment in these cells (Fig. 5, C and D). Together, these results 
suggest that FIP200 functions as a suppressor of TNFα-induced 
apoptosis, and increased susceptibility to TNFα-induced apop-
tosis may play an important role in the heart and liver defects 
and embryonic lethality in FIP200 KO mice.
Defective JNK signaling is responsible 
for increased TNF𝗂-stimulated apoptosis 
in FIP200 KO cells
To investigate the mechanisms by which FIP200 deletion leads 
to increased susceptibility to TNFα-induced apoptosis, we fi  rst 
examined potential changes in the NF-κB pathway, which is one 
of the major cell survival pathways activated by TNFα (Chen 
and Goeddel, 2002). We tested whether TNFα induced IκBα 
phosphorylation and degradation is affected in FIP200 KO 
MEFs, which is the biochemical indicator for NF-κB activation 
by TNFα stimulation. Fig. 6 A shows rapid induction of phos-
phorylation (very signifi   cant given the dramatically reduced 
  levels of IκBα protein upon stimulation) and degradation of 
IκBα at 10 min after stimulation in both FIP200 KO and WT 
MEFs. At 30 min after TNFα treatment, IκBα protein reap-
peared as expected because of translocation of freed NF-κB to 
the nucleus and its activation of the transcription of IκBα itself 
in both cells. Furthermore, TNFα stimulation increased NF-κB 
transcription activity to similar levels in both FIP200 KO and 
WT MEFs   (unpublished data). These results suggest that dele-
tion of FIP200 did not affect TNFα- induced NF-κB activation.
TNFα stimulation also leads to JNK activation, which can 
promote either cell survival or death, depending on the cellular 
context (Davis, 2000). Interestingly, JNK1 and -2 double-KO 
MEFs also exhibit more sensitivity to TNFα-induced apoptosis 
(Lamb et al., 2003). We therefore examined whether JNK sig-
naling is affected in FIP200 KO MEFs. Fig. 6 B shows that in-
duction of JNK phosphorylation (both the transient and robust 
JNK activation within the fi  rst 30 min, and the later sustained 
Figure 4.  Increased apoptosis in FIP200 KO embryos. 
  Immunohistochemical staining of heart (A) and liver (B) sec-
tions from FIP200 WT (+/+) and KO (∆/∆) embryos at 
E12.5 or E14.5 with antibody against cleaved caspase-3. 
There is no immunostaining observed in heart or liver sections 
from either the KO or WT embryo section at E12.5 or in the 
WT embryo at E14.5. In contrast, in the KO embryo at E14.5, 
selected myocardial cells (arrows) show intense cytoplasmic 
and nuclear staining. Many hepatocytes also show intense 
cytoplasmic and nuclear staining. In the high-magniﬁ  cation 
inset, selected hepatocytes are marked with arrows.FIP200 IN EMBRYONIC DEVELOPMENT AND SIGNALING • GAN ET AL. 127
and weaker JNK activation) in response to TNFα stimulation 
was signifi  cantly reduced in FIP200 KO MEFs compared with 
WT MEFs. Consistent with this, phosphorylation of c-Jun on 
both serine 63 and 73 upon TNFα stimulation was also lower in 
FIP200 KO MEFs than that in WT MEFs (Fig. 6 C). We also 
observed that TNFα stimulation increased c-Jun protein level, 
which is consistent with the previous observations that JNK-
mediated c-Jun phosphorylation protected c-Jun from ubiquitin-
dependent degradation, resulting in increased c-Jun protein 
levels (Fig. 6 C; Musti et al., 1997). The increase of c-Jun pro-
tein level in response to TNFα stimulation was reduced in 
FIP200 KO MEFs, consistent with the reduced JNK phosphor-
ylation in response to TNFα stimulation in FIP200 KO MEFs 
(Fig. 6 C). Furthermore, we found that reexpression of FIP200 
in the FIP200 KO MEFs restored JNK activation in response to 
TNFα stimulation (Fig. 6 D), suggesting the JNK phosphoryla-
tion defect observed in FIP200 KO MEFs is a direct conse-
quence of FIP200 deletion.
To determine whether the reduced JNK activation in 
FIP200 MEFs is responsible for the increased TNFα-induced 
apoptosis, we examined the effect of restoration of JNK activity 
on TNFα-induced apoptosis in these cells. Transient transfec-
tion of FIP200 KO MEFs with an expression vector encoding 
JNK restored JNK activity as measured by the increased c-Jun 
phosphorylation in these cells (Fig. 6 E). This increased JNK 
activity signifi  cantly  suppressed TNFα-induced apoptosis in 
FIP200 KO MEFs (Fig. 6 F), suggesting that the increased sen-
sitivity of FIP200 KO MEFs to TNFα-induced apoptosis is 
caused by the defective JNK activation in these cells.
The aforementioned results from analyses in MEFs raised 
the possibility that the increased apoptosis in the liver and heart 
of FIP200 KO embryos is also due to reduced JNK activity in 
these embryos. To test this possibility directly, we fi  rst exam-
ined JNK activation status in embryonic liver and heart of 
FIP200 KO. Consistent with results in MEFs, Western blotting 
analysis of liver and heart protein extracts showed that JNK 
phosphorylation was decreased in FIP200 KO embryos com-
pared with WT littermate embryos (Fig. 6 G). Immunohisto-
chemical analysis of liver sections by anti–phospho-JNK also 
showed reduced JNK activity in FIP200 KO embryos (unpub-
lished data). We then isolated primary liver cells from FIP200 
KO and control WT embryos and examined their JNK activation 
and apoptosis in response to TNFα stimulation.  Similar to the 
results in MEFs, we found that TNFα-induced JNK activation 
was reduced in liver cells from FIP200 KO embryos compared 
with that from control WT embryos (Fig. 6 H). Also consistent 
with results in MEFs, liver cells from FIP200 KO embryos ex-
hibited increased sensitivity to TNFα-induced apoptosis and 
Figure 5.  Increased susceptibility of FIP200 KO MEFs to 
TNF𝗂-induced apoptosis. (A) Primary FIP200 KO and WT 
MEFs were cultured in DME supplemented with 10% FBS. The 
cells were left untreated; treated for 1 d with 200 mM sorbi-
tol, 10 μM anisomycin, 5 ng/ml Fas-L, 1 μg/ml TRAIL, and 
50 ng/ml TNFα; or cultured in glucose-free medium for 2 d, 
as indicated. They were then stained with Hoechst to deter-
mine the fraction of apoptotic cells, as described in Materials 
and methods. The mean + SEM from at least three experi-
ments is shown. *, P < 0.001. (B) Primary FIP200 KO and 
WT MEFs were either left untreated or treated for 1 d with 
50 ng/ml TNFα. The fraction of apoptotic cells, necrotic cells, 
or dead cells (including both apoptotic and necrotic cells) was 
determined by acridine orange and ethidium bromide cost-
aining. The mean + SEM from at least three experiments is 
shown. (C) FIP200 KO MEFs were transfected with plasmid 
encoding HA-tagged FIP200 (ﬁ  fth and sixth lanes) or empty 
vector as a control (third and fourth lanes). 1 d after transfec-
tion, these and WT MEFs (ﬁ  rst and second lanes) were treated 
with or without 50 ng/ml TNFα for another day, as indicated. 
Cell lysates were prepared and analyzed by Western blotting 
using antibodies against cleaved caspase-3, FIP200, and 
  vinculin, as indicated. (D) FIP200 KO MEFs were transfected 
with empty vector or vector encoding HA-FIP200, along with 
pEGFP (3:1 ratio). The cells were either left untreated or 
treated for 1 d with 50 ng/ml TNFα, as indicated. They were 
then stained with Hoechst to determine the fraction of apop-
totic cells in EGFP-positive cells. The mean + SEM from at 
least three experiments is shown. JCB • VOLUME 175 • NUMBER 1 • 2006  128 
overexpression of JNK suppressed the increased apoptosis in 
these cells (Fig. 6 I). Collectively, these results suggest that 
FIP200 is required for TNFα-induced JNK activation, and re-
duced JNK activation and its prosurvival function upon FIP200 
deletion may be responsible for the increased susceptibility to 
TNFα-induced apoptosis in FIP200 KO MEFs and hepatocytes, 
which may contribute to the increased apoptosis and embryonic 
lethality observed in FIP200 KO embryos.
Interaction of FIP200 with ASK1 
and TRAF2 and its role in TNF𝗂 
signaling to JNK
To explore potential mechanisms by which FIP200 participates 
in the stimulation of JNK signaling by TNFα, we fi  rst examined 
whether FIP200 could affect JNK signaling through its effects 
on FAK and/or Pyk2. We found that TNFα stimulation did not 
affect FAK and Pyk2 activation, whereas under the same condi-
tion, JNK was potently activated (Fig. 7 A). Furthermore, similar 
phosphorylation levels of FAK and Pyk2 were observed in 
FIP200 KO and WT MEFs, although previous studies showed 
inhibition of FAK and Pyk2 by overexpression of FIP200 in 
other cells (Ueda et al., 2000; Abbi et al., 2002). These results 
suggested that FAK and Pyk2 were not involved in FIP200 regu-
lation of TNFα-induced JNK activation.
Previous studies documented that TNFα activates JNK 
through TNFR-TRAF2-ASK1-MKK4/MKK7-JNK signaling 
cascade (Davis, 2000). Thus, we examined whether FIP200 was 
capable of interacting with any of the components in the cas-
cade. Interestingly, we observed that FIP200 could interact with 
both ASK1 and TRAF2. Fig. 7 B shows coimmunoprecipitation 
of Myc-FIP200 with HA-ASK1 by anti-HA precipitation (left) 
and reciprocal coimmunoprecipitation of HA-ASK1 with Myc-
FIP200 by anti-Myc precipitation (right), when both were trans-
fected into 293T cells. Similar coimmunoprecipitation studies 
showed association of HA-FIP200 with Myc-TRAF2 in 293T 
cells (Fig. 7 C). Consistent with these transfection studies, 
Figure 6.  Reduced JNK activation in response 
to TNF𝗂 stimulation in FIP200 KO cells and 
  embryos.  (A–C) FIP200 KO and WT MEFs 
were serum starved overnight. They were then 
left untreated or treated with 50 ng/ml TNFα 
for the different periods of time, as indicated. 
Cell lysates were then analyzed by Western 
blotting with various antibodies as indicated. 
(D) FIP200 KO and WT MEFs were infected 
with recombinant adenoviruses encoding 
FIP200 (Ad-FIP200) or GFP (Ad-GFP, as con-
trol), as indicated. 1 d after infection, cells 
were serum starved overnight and were left un-
treated or treated with 50 ng/ml TNFα for 10 
min. Cell lysates were analyzed by Western 
blotting with various antibodies as indicated. 
(E and F) FIP200 KO MEFs were transfected 
with empty vector or vector encoding Myc-
JNK1, along with pEGFP (3:1 ratio). The cells 
were either left untreated or treated for 1 d 
with 50 ng/ml TNFα, as indicated. Cell lysates 
were prepared and analyzed by Western blot-
ting with various antibodies, as indicated (E). 
Alternatively, the cells were stained with 
Hoechst to determine the fraction of apoptotic 
cells in EGFP-positive populations. The mean + 
SEM from at least three experiments is shown (F). 
(G) Western blotting analysis of heart and 
liver protein extracts from FIP200 WT (+/+) 
and KO (∆/∆) embryos using antibodies 
against phospho-JNK or JNK, as indicated. 
(H) Hepatocytes isolated from FIP200 WT (+/+) 
and KO (∆/∆) embryos were serum starved 
overnight. They were then left untreated or 
treated with 50 ng/ml TNFα for the different 
periods of time, as indicated. Cell lysates were 
then analyzed by Western blotting with phos-
pho-JNK or JNK antibodies, as indicated. 
(I) FIP200 KO hepatocytes were transfected with 
empty vector or vector encoding Myc-JNK1, 
along with pEGFP (3:1 ratio). The cells were 
either left untreated or treated for 1 d with 50 
ng/ml TNFα, as indicated. They were then 
stained with Hoechst to determine the fraction 
of apoptotic cells in EGFP-positive populations. 
The mean + SEM from at least three experi-
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we also detected the interaction of endogenous FIP200 with the 
endogenous ASK1 and TRAF2 in MEFs (Fig. 7 D). We next de-
termined the regions of FIP200 responsible for its association 
with ASK1 and TRAF2. We found that the FIP200 C-terminal 
region (CT), but not the N-terminal 859 residues (N1-859) or 
the CC (Fig. 8 A), could associate with ASK1 (Fig. 8, A and B). 
In contrast, CC, but not CT or N1-859, coprecipitated with 
TRAF2 (Fig. 8, A and C). These results demonstrated that 
FIP200 could interact with TRAF2 and ASK1 through two sep-
arate regions of the molecule.
Previous studies have shown that TRAF2 stimulates 
TNFα-induced JNK activation through TRAF2 interaction with 
ASK1 and TRAF2-mediated ASK1 activation (Nishitoh et al., 
1998). Thus, our identifi  cation of FIP200 interaction with both 
TRAF2 and ASK1 through different regions raised the interest-
ing possibility that FIP200 may play a role in TNFα-induced 
JNK activation by serving as a scaffold to facilitate TRAF2-
ASK1 signaling to JNK activation. To test this possibility di-
rectly, we fi  rst evaluated whether TNFα-induced TRAF2–ASK1 
interaction and ASK1 activation is reduced in FIP200 KO MEFs 
compared with WT control MEFs. Consistent with previous 
  reports (Nishitoh et al., 1998; Noguchi et al., 2005), we found 
that TNFα treatment increased TRAF2 interaction with ASK1 
and stimulated activation of ASK1 as measured by phosphory-
lation of ASK1 at threonine 845 in WT MEFs (Fig. 8 D). 
  Deletion of FIP200 signifi  cantly  reduced  TNFα-stimulated 
TRAF2–ASK1 interaction and ASK1 phosphorylation in 
FIP200 KO MEFs compared with that in WT MEFs, which 
could be rescued by reexpression of FIP200 in FIP200 KO 
MEFs. We then determined whether overexpression of FIP200 
CC or CT segment, which is expected to compete with endoge-
nous FIP200 to reduce its interaction with TRAF2 or ASK1, 
  respectively, will affect TRAF2–ASK1 interaction and ASK1 
activation. Fig. 8 E shows that overexpression of either of 
these two segments, but not N1-859 segment, functioned in a 
dominant-negative manner to inhibit TRAF2 interaction with 
ASK1. Furthermore, overexpression of FIP200 CC or CT, but 
not N1-859 segment, could reduce ASK1 phosphorylation (Fig. 
8 F, left). Consistent with the reduced ASK1 activation, they 
also reduced JNK activation in these cells (Fig. 8 F, right). 
  Finally, we found that overexpression of FIP200 CC or CT 
 segment   increased  TNFα stimulation–induced apoptosis in 
MEFs (Fig. 8 G) and hepatocytes (not depicted). Together, 
these results identifi  ed novel interactions of FIP200 with ASK1 
and TRAF2, which might mediate FIP200 regulation of ASK1 
and JNK   activation in response to TNFα stimulation.
Discussion
Our analysis of the FIP200 KO embryos showed their defective 
cardiac and liver development and mid/late embryonic lethality 
caused by heart failure and liver degeneration. A role for FIP200 
in cardiac formation and development is indicated by the se-
verely affected myocardium with sparsely cellular myocardium 
forming thinner ventricular walls, as well as ventricular dilation 
and generalized edema, suggesting cardiac failure in the FIP200
KO embryos. Interestingly, on the other hand, TSC1 and -2 KO 
embryos also exhibited severe heart defects with thickened ven-
tricular walls (Kobayashi et al., 1999, 2001). The opposite de-
fective cardiac phenotypes suggested that FIP200 might function 
to antagonize TSC in the regulation of the thickness of the ven-
tricular wall during heart development. This is consistent with 
our recent fi  ndings showing FIP200 interactions with TSC1 that 
inhibit TSC1–TSC2 complex function in vitro (Gan et al., 
2005). They also suggest that a balance between positive and 
negative regulation of ventricular wall thickness by FIP200 and 
TSC, respectively, is critical for the normal cardiac develop-
ment in embryogenesis.
Consistent with the opposite cardiac phenotype of the 
FIP200 and TSC KO embryos and our previous in vitro fi  ndings 
of inhibition of TSC functions by FIP200 (Gan et al., 2005), we 
found increased TSC activity in the FIP200 KO embryos as 
measured by a decreased activation of S6K in cardiomyocytes 
and hepatocytes as well as when the whole FIP200 KO embryo 
extracts were analyzed. Furthermore, we observed reduced cell 
size in the heart and liver of FIP200 KO embryos (Fig. 3, D and E), 
as well as isolated FIP200 KO MEFs (Fig. 3 C). We noted that 
the reduction in the size of FIP200 KO MEFs ( 5%) is not 
Figure 7.  Association of FIP200 with ASK1 and TRAF2. (A) FIP200 KO 
and WT MEFs were serum starved overnight. They were then left untreated 
or treated with 50 ng/ml TNFα for 10 min, as indicated. Cell lysates were 
then analyzed by Western blotting with various antibodies, as indicated. 
(B) 293T cells were cotransfected with vector encoding HA-ASK1 or empty 
vector and plasmid encoding Myc-FIP200 or empty vector, as indicated. 
Cell lysates were immunoprecipitated with anti-HA or anti-Myc and ana-
lyzed by Western blotting with anti-Myc and anti-HA, as indicated. 
Aliquots of whole cell lysates (WCL) were also analyzed directly by West-
ern blotting with anti-Myc and anti-HA, as indicated. (C) 293T cells were 
cotransfected with vector encoding Myc-TRAF2 or empty vector and plas-
mid encoding HA-FIP200. Cell lysates were immunoprecipitated with anti-
Myc and analyzed by Western blotting with anti-FIP200 or anti-Myc, as 
indicated. Aliquots of the lysates were also analyzed directly by Western 
blotting with anti-FIP200. (D) Lysates from MEFs were immunoprecipitated 
by anti-ASK1 or anti-TRAF2 or an irrelevant antibody as control, as indi-
cated. They were then analyzed by Western blotting with anti-FIP200, 
anti-ASK1, or anti-TRAF2, as indicated. Aliquots of the lysates were also 
analyzed directly.JCB • VOLUME 175 • NUMBER 1 • 2006  130 
as pronounced as liver and heart cells in the FIP200 KO 
embryos. The relatively modest changes in the size of MEFs may 
account for their apparently normal functions in vivo. It is also 
possible that the functions of fi  broblasts in vivo are less depen-
dent on the changes in these signaling pathways (thus appar-
ently lack of any defective phenotypes in earlier embryogenesis) 
than cells in the heart and liver, which are organs characterized 
by high metabolic activities in mid/late gestation that may be 
more tightly regulated by protein synthesis and cell growth. 
Consistent with this notion, both TSC1 and -2 KO embryos 
also showed major defects in heart and liver development 
  (Kobayashi et al., 1999, 2001; Onda et al., 1999; Kwiatkowski 
et al., 2002). Therefore, a role of FIP200 in the regulation of cell 
size/cell growth may contribute to its potential function in heart 
and liver development as revealed in the current study.
It has been shown that cell size increase is a prerequisite 
for cell proliferation during normal organ growth (Conlon and 
Raff, 1999). Thus, it would be expected that the cell size de-
crease observed in FIP200 KO embryos would also lead to a 
cell proliferation defect. However, we did not detect any defects 
in cell cycle progression in the heart or liver in the FIP200 KO 
embryos (unpublished data). Although cell size and prolifera-
tion are coordinately regulated in many cases,  these two cellu-
lar processes have also been shown to be uncoupled under some 
conditions where change in cell size does not necessarily affect 
cell proliferation. For example, deletion of S6K1 reduces the 
size of myoblasts without affecting their proliferation (Ohanna 
et al., 2005). In other cases, cell size and proliferation are regu-
lated in an opposite manner. For example, it was shown that Rb 
triple-KO MEFs (lacking all three Rb family proteins pRb, 
Figure 8.  Role of FIP200 interaction with 
TRAF2 and ASK1 in its regulation of TNF𝗂 
  signaling to JNK. (A) Schematic diagram 
showing the different regions of FIP200 and 
a summary of their ability to interact with 
ASK1 or TRAF2. (B and C) 293T cells were 
cotransfected with vector encoding HA-ASK1 
or empty vector and plasmid encoding Myc-
CT or -CC (B) or vector encoding Myc-TRAF2 
or empty vector and plasmid encoding HA-
CT or HA-CC (C), as indicated. Cell lysates 
were immunoprecipitated with anti-HA or 
anti-Myc and analyzed by Western blotting 
with anti-Myc and anti-HA, as indicated. Ali-
quots of whole cell lysates (WCL) were also 
analyzed directly by Western blotting with 
anti-Myc or anti-HA, as indicated. (D) FIP200 
KO MEFs were transfected with plasmid en-
coding HA-tagged FIP200 (ﬁ   fth and sixth 
lanes) or empty vector as a control (third and 
fourth lanes), and WT MEFs were transfected 
with empty vector. HA-ASK1 was also co-
transfected in each transfection. 1 d after 
transfection, cells were serum starved over-
night. They were then left untreated or 
treated with 50 ng/ml TNFα for 10 min, as 
indicated. Cell lysates were then immunopre-
cipitated with anti-TRAF2 and analyzed by 
Western blotting with anti-ASK1 and anti-
TRAF2, as indicated. Aliquots of the lysates 
were also analyzed by Western blotting with 
phospho-ASK1 (Thr845), ASK1, or FIP200 
antibodies, as indicated. (E) Lysates from 
cells transfected with HA-CC, HA-CT, HA-
N1-859, or empty vector were mixed 
with lysates from cells cotransfected with 
HA-ASK1 and Myc-TRAF2. Cell   lysates were 
then immunoprecipitated with anti-Myc and 
analyzed by Western blotting with anti-Myc 
and anti-ASK1, as indicated.   Aliquots of the 
lysates were also analyzed   directly by West-
ern blotting, as indicated. (F) 293T cells 
were cotransfected with vectors encoding 
HA-CC, HA-CT, HA-N1-859, or empty vector 
and plasmid encoding HA-ASK1 (left) or 
Myc-JNK1 (right). Cell lysates were then an-
alyzed by Western blotting with various anti-
bodies, as indicated. The phosphorylation 
levels of ASK1 and JNK are normalized to 
the expression levels of HA-ASK1 and Myc-
JNK, and mean + SEM from three   independent experiments are shown on the bottom. (G) MEFs were transfected with empty vector or vector encod-
ing HA-CC, HA-CT, or HA-N1-859, along with pEGFP (3:1 ratio). The cells were either left untreated or treated for 1 d with 50 ng/ml TNFα, as 
indicated. They were then stained with Hoechst to determine the fraction of apoptotic cells in EGFP-positive cells. The mean + SEM from at least 
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p107, and p130) showed a signifi  cantly reduced cell size but an 
increased cell proliferation, when compared with control MEFs 
(Sage et al., 2000). Thus, it is likely that FIP200 function in 
these two cellular processes might be uncoupled during embry-
onic development.
Large truncation deletion of the FIP200 gene has been 
observed in  20% of primary breast cancers screened in a re-
cent study, implicating a potential role of FIP200 as a tumor 
suppressor (Chano et al., 2002b). However, heterozygous dele-
tion of FIP200 has not led to development of mammary or any 
other tumors within 1 yr of age so far (unpublished data). It is 
possible that one WT allele remaining in FIP200 heterozygous 
mice is suffi  cient to maintain its potential tumor suppressor 
function. It has been shown that, for many tumor suppressor 
genes, the germline single-allele loss in combination with sto-
chastic somatic loss would lead to an increased tumor incidence 
in certain organs. For example, total deletion of tumor suppres-
sor gene Brca1 leads to embryonic lethality phenotype, and 
Brac1 heterozygous mice don’t develop tumors. Notably, intro-
duction of a p53-null allele signifi  cantly enhances mammary 
gland tumor formation in Brca1 mammary gland conditional 
KO mice (Deng and Scott, 2000). Therefore, it is possible that 
combination with another allele that enhances breast cancer de-
velopment might be synergistic in breast cancer development in 
FIP200 heterozygous mice. Future studies using FIP200 condi-
tional KO mice combined with crossing with other mice tumor 
models will be necessary to overcome the embryonic lethality 
of homozygous deletion of FIP200 and clarify its potential role 
as a tumor suppressor in vivo.
Our results suggested that increased apoptosis in FIP200 
KO embryos may be caused by an increased susceptibility 
to TNFα-induced apoptosis. Furthermore, defective JNK 
  signaling was shown to be responsible for increased TNFα-
stimulated apoptosis in FIP200 KO cells, which may contrib-
ute to the increased apoptosis and embryonic lethality 
observed in FIP200 KO embryos. The exact role of JNK in 
TNFα-regulated cell survival/death is complex and remains 
somewhat controversial. Some studies suggest an essential 
role for JNK in TNFα-induced cell death (De Smaele et al., 
2001; Deng et al., 2003). Other studies indicate that JNK is 
not essential for TNFα-induced cell death (Liu et al., 1996) 
and may suppress TNFα-stimulated apoptosis (Lee et al., 
1997; Roulston et al., 1998; Reuther-Madrid et al., 2002; 
Lamb et al., 2003). These studies together suggest a model in 
which JNK regulates TNFα-induced cell death in a temporal 
fashion such that early transient JNK activation upon TNFα 
stimulation suppresses TNFα-stimulated apoptosis, whereas 
late sustained JNK activation promotes TNFα-induced cell 
death (Ventura et al., 2006). Consistent with this model, our 
data showed that FIP200 KO cells exhibited decreased tran-
sient JNK activation (Fig. 6, B and H) and increased apopto-
sis upon TNFα stimulation (Fig. 6, F and I). Our study thus 
suggests that the increased apoptosis in FIP200 KO cells is 
mainly mediated by the reduction of transient JNK activation 
and that overexpression of JNK in FIP200 KO cells can sup-
press TNFα-induced apoptosis possibly by restoration of 
transient JNK activation.
Materials and methods
Construction of the targeting vector, and generation of FIP200 KO mice
Based on the available mouse genome sequence in the database, a DNA 
fragment in the intron between exons 4 and 5 was obtained by PCR. This 
fragment was then used to isolate mouse FIP200 genomic clones from 
BAC library derived from isogenic 129SvJ mice (Genome Systems, Inc.) 
by PCR. A targeting vector was then constructed that contains a 1.7-kb left 
arm, with exons 4 and 5 ﬂ  anked by two loxP sites followed by a neo cas-
sette gene and a third loxP site, a 5-kb right arm, and a HSV-TK gene. The 
linearized targeting vector was transfected into the E14.1 embryonic stem 
(ES) cells, and homologous recombinant clones were identiﬁ  ed by South-
ern blotting analysis using a fragment outside of the left arm as probe 
(Fig. 1 A). The recombinant clone was used to generate chimeric mice by 
injection into C57BL/6 blastocytes. Male chimeras (identiﬁ  ed by the pres-
ence of agouti coat color) were then mated with C57BL/6 females to 
  determine germline transmission. The targeted allele was successfully 
transmitted to the germline cells, as identiﬁ  ed by Southern blotting analy-
sis using the same conditions for the detection of the homologous recom-
bination event in the ES cells, which generated the heterozygote targeted 
mice designated as FIP200
ﬂ  oxNeo/+ mice. All mice used in the study were 
bred and maintained at Cornell University Transgenic Animal Core Facil-
ity (Ithaca, NY) under speciﬁ   c pathogen-free conditions in accordance 
with institutional guidelines.
Genotype analysis by PCR
The following primers were used in PCR genotyping: P1, 5′-G  G  A  A  C  C  A  C  G-
C  T  G  A  C  A  T  T  T  G  A  C  A  C  T  G  -3′; P2, 5′-C  A  A  A  G  A  A  C  A  A  C  G  A  G  T  G  G  C  A  G  T  A  G  -3′; 
and P3, 5′-C  A  T  C  A  G  A  T  A  C  A  C  T  A  G  A  G  C  T  G  G  -3′. The combination of 
  primers P1 and P3 ampliﬁ  es an  800-bp fragment from FIP200
∆   allele. 
The combination of primers P2 and P3 ampliﬁ  es 262- and 225-bp frag-
ments from WT and FIP200
ﬂ o x alleles, respectively. The PCR condition is 
as follows: 3 cycles at 94°C for 3 min, 60°C for 1 min, and 72°C for 
2 min, followed by 33 cycles at 94°C for 1 min, 60°C for 1 min, and 
72°C for 2 min, and 1 cycle at 94°C for 1 min, 60°C for 1 min, and 72°C 
for 10 min.
Antibodies and reagents
The rabbit antiserum against FIP200 and Pyk2 have been described previ-
ously (Zheng et al., 1998; Ueda et al., 2000). The mouse monoclonal 
α-vinculin and Tyrosine397 phospho-FAK antibodies were obtained from 
Upstate Biotechnology. The rabbit polyclonal α-HA (Y11) antibody, the 
mouse monoclonal α-c-Myc-tag (9E10) antibody, rabbit polyclonal α-FAK 
(C20) antibody, rabbit polyclonal and mouse monoclonal ASK1 anti-
bodies, rabbit polyclonal and mouse monoclonal TRAF2 antibodies, and 
rabbit polyclonal S6K antibody were obtained from Santa Cruz Biotech-
nology,  Inc. JNK1/2 antibody was obtained from BD Biosciences. 
Cleaved   caspase-3, Tyr402 phospho-Pyk2, phospho-JNK, c-Jun, Ser63 
phospho-c-Jun, Thr845 phospho-ASK1, Ser73 phospho-c-Jun, IκBα, Ser32-
phospho-IκBα, Ser473 phospho-Akt, Akt, Thr1462 phospho-TSC2, 
Ser240/244 phospho-S6, S6, Thr389 phospho-S6K, Thr37/46 phospho-
4EBP1, and 4EBP1 antibodies were purchased from Cell Signaling Tech-
nology, Inc. Sorbitol, acridine orange, and anisomycin were obtained from 
Sigma-  Aldrich. TNFα was obtained from Calbiochem, TRAIL was provided 
by J. Yuan (Harvard Medical School, Boston, MA), and Fas-L was provided 
by Z. Liu (National Cancer Institute, Bethesda, MD). D-glucose–free DME 
and ethidium bromide were obtained from Invitrogen.
Cell culture
The FIP200 KO and WT MEFs were isolated from E12.5 embryos and 
  cultured in DME supplemented with 10% FBS. 293T cells were cultured in 
DME supplemented with 10% FBS.
Plasmids and recombinant adenoviruses
Vectors encoding HA-FIP200, HA-FIP200 N1-859, and HA-FIP200 CT 
were described previously (Abbi et al., 2002; Gan et al., 2005). The CC 
of FIP200 (860–1401 aa) was ampliﬁ  ed by PCR and then subcloned into 
HA tag–containing vector pKH3 to generate plasmid HA-FIP200 CC. Full-
length FIP200, FIP200 N1-859, CC, and CT fragments were then sub-
cloned from corresponding pKH3 vectors into Myc tag–containing pHAN 
vector (Han et al., 2002), resulting in Myc-FIP200, Myc-FIP200 N1-859, 
Myc-FIP200 CC, and Myc-FIP200 CT. The HA-ASK1 construct was pro-
vided by H. Fu (Emory University, Atlanta, GA), and the NF-κB reporter 
construct was provided by A. Lin (University of Chicago, Chicago, IL). Full-
length mouse JNK1 and TRAF2 cDNA were ampliﬁ  ed by RT-PCR and then JCB • VOLUME 175 • NUMBER 1 • 2006  132 
subcloned into Myc tag–containing pHAN vector to generate the plasmids 
Myc-JNK1 and -TRAF2, respectively. The recombinant adenovirus Ad-FIP200 
was generated as previously described (Melkoumian et al., 2005).
Immunoprecipitation and Western blotting
Tissue samples and embryos were homogenized, and extracts were used 
for Western blotting analysis as described previously (Peng et al., 2004). 
Preparation of whole cell lysates, immunoprecipitation, and Western 
  blotting were performed as previously described (Abbi et al., 2002).
Histological and immunohistochemical analysis
Histological and immunohistochemical analysis were performed as previ-
ously described (Peng et al., 2004). The histological and immunohisto-
chemical slides were examined under a microscope (model BX41; 
Olympus) with UplanF1 10×/0.3 objective lens at RT, and the images 
were captured using a camera (model DP70; Olympus) with DP Controller 
version 1.2.1.108.
Determination of cell size by WGA-TRITC staining and FACS analysis
To determine cell size by WGA staining, after deparafﬁ  nization and rehy-
dration, tissue sections were stained with 150 μg/ml WGA tetramethylrho-
damine conjugate (Invitrogen) at 37°C for 30 min and washed with PBS 
three times, each for 4 min. The samples were mounted for analyses by im-
munoﬂ  uorescent microscopy. The area of cross section of cells was quanti-
ﬁ  ed by NIH Image program. To determine the cell size of cultured cells, 
FACS analysis with Cell Quest software (BD Biosciences) was performed as 
previously described (Inoki et al., 2003).
Apoptosis assays
Apoptosis assays were done as previously described (Ueda et al., 2000). 
The numbers of apoptotic and necrotic cells were determined by ﬂ  uorescent 
dye costaining with acridine orange and ethidium bromide as described 
previously (Xu et al., 1996).
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